Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Aridis Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 18 | 1 | −17 |
| Shares | 1.78M | 14.1K | −1.77M (−99.2%) |
| Value | $392.3K | $1.44K | −$390.9K (−99.6%) |
New holders (0)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
None.
Sold out (17)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Commonwealth Equity Services, LLC | 646,000 | $142.0K |
| Roumell Asset Management, LLC | 446,588 | $98.2K |
| State Street Corp | 202,247 | $44.5K |
| Geode Capital Management, LLC | 143,034 | $31.5K |
| Vanguard Group Inc | 136,197 | $29.9K |
| HRT Financial LP | 73,723 | $16.0K |
| Acadian Asset Management LLC | 36,533 | $8.00K |
| Northern Trust Corp | 28,104 | $6.18K |
| Cornerstone Wealth Management, LLC | 20,000 | $4.40K |
| Tower Research Capital LLC (TRC) | 16,363 | $3.60K |
| Virtu Financial LLC | 11,809 | $3.00K |
| BlackRock Inc. | 4,612 | $1.01K |
| Group One Trading, L.P. | 2,337 | $514 |
| Wells Fargo & Company | 1,459 | $320 |
| ICA Group Wealth Management, LLC | 250 | $55 |
| Financial Perspectives, Inc | 250 | $55 |
| Simplex Trading, LLC | 1,293 | $0 |